Wed Jun 25 17:07:35 UTC 2025: Here’s a news article summarizing the provided text, keeping the Indian perspective in mind:
**India and US Forge Deeper Tech Ties Amid Global Uncertainty**
**Bengaluru, June 25, 2025:** Leading figures from the Indian and U.S. business and technology sectors gathered at the U.S. Chamber of Commerce’s U.S.-India Business Council (USIBC) conclave in Bengaluru on Wednesday, emphasizing the vital need for strengthened collaboration across key technological domains. The discussions, coinciding with USIBC’s 50th anniversary, highlighted the potential for the two nations to co-develop AI infrastructure, quantum technologies, biotechnology, defense systems, space exploration, and AIoT (Artificial Intelligence of Things).
U.S. Consul General in Chennai, Chris Hodges, noted the centrality of commerce to the U.S.-India partnership, underscoring the strategic collaboration under the TRUST initiative, which covers AI, quantum computing, semiconductors, biotechnology, and space.
USIBC President Ambassador Atul Keshap (Retd) echoed this sentiment, stating, “Fifty years ago, USIBC was born out of a belief that the U.S. and India could accomplish more together. Today, we are building the next 50 on that same foundation of trust.”
Karnataka’s Minister of Electronics, Information Technology & Biotechnology, Priyank Kharge, reiterated the state’s readiness to serve as a central hub for global innovation, leveraging its talent pool and infrastructure.
Biocon Ltd. founder, Kiran Mazumdar-Shaw, emphasized the evolution of the relationship beyond trade to deep scientific and technological collaboration. She called for a shift towards joint capability-building to foster resilience and inclusivity in the face of geopolitical uncertainties. Ms. Shaw anticipates that economic growth will be driven by digital technologies, AI and high-quality data. “Data exchanges will form the foundation of a bilateral trade agreement between US and India which is to be announced shortly,” she said.
Ms. Mazumdar-Shaw highlighted India’s critical role in providing STEM talent to the U.S., with over 2 million professionals contributing to technology and innovation. U.S. companies are increasingly investing in India’s AI, semiconductor, clean energy, and digital infrastructure sectors, while Indian companies are expanding their investments in the U.S., particularly in IT services, technology R&D, digital health, biomanufacturing, and advanced analytics.
The pharmaceutical sector was also identified as a crucial pillar of the partnership, with India supplying over 45% of generic and 15% of biosimilar volumes consumed in the U.S. annually. According to Ms. Mazumdar-Shaw, these generics and biosimilars have saved the U.S. healthcare system over $3 trillion in the past decade, expanding insurance coverage and access to essential medicines.
The conclave reaffirmed the commitment of both nations to deepen their strategic partnership, fostering innovation and stability in an increasingly complex global landscape.